ILLUMINA INC. DL-,01 | 331.30 / -1.55% |
Date/Time | 03/05 / 08:00 |
Chg. / Chg.(%) | -5.20 / -1.55% |
Bid | - |
Ask | - |
Open | 331.30 |
Previous Close | 336.50 |
High | 331.30 |
Low | 331.30 |
Volume [EUR] | 0.00 |
Volume [Units] | 0 |
Price fixings | 1 |
ISIN | US4523271090 |
Security | ILU |
Exchange | München |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Lang & Schwa.. | 335.400 | ![]() |
|
NASDAQ | 398.8500 | ![]() |
1,181,765 |
IEX | 398.48 | ![]() |
77,550 |
Cboe US | 398.86 | ![]() |
76,894 |
TradeGate | 334.550 | ![]() |
1,821 |
London Inter.. | 387.58 | ![]() |
648 |
Vienna Globa.. | 325.50 | ![]() |
371 |
Düsseldorf | 332.05 | ![]() |
74 |
Xetra | 339.20 | ![]() |
42 |
Frankfurt | 332.6500 | ![]() |
40 |
Stuttgart | 334.350 | ![]() |
39 |
gettex | 333.500 | ![]() |
20 |
Mexico | 8,150.00 | ![]() |
17 |
Berlin | 332.55 | ![]() |
0 |
München | 331.30 | ![]() |
0 |
News
- Myriad Genetics Joins Forces with Intermountain Precision Genomics for a Comprehensive Offering of Germline and Somatic Tumor Testing Services
03/02/2021 / 13:05 - GlobeNewswire - Kura Oncology Reports Fourth Quarter and Full Year 2020 Financial Results
02/24/2021 / 13:20 - GlobeNewswire - Myriad Genetics Delivers 6% Sequential Revenue Growth; Company Continues to Execute Strategic Transformation Plan
02/23/2021 / 22:05 - GlobeNewswire - Seer Appoints Deep Nishar and Mostafa Ronaghi, Ph.D. to its Board of Directors
02/17/2021 / 14:00 - GlobeNewswire - US closes higher, finishes week with new record highs
02/12/2021 / 22:00 - TeleTrader